Jeff Aronin, Chairman and CEO of Paragon Biosciences, has spent more than two decades in one of the most challenging areas of the biosciences sector. He and his teams have worked to find treatments for… Read more
CHICAGO–(BUSINESS WIRE)–May 13, 2019– Paragon Biosciences, LLC Chairman and CEO Jeff Aronin was recently recognized by the Northern Illinois University (NIU) College of Business as the 2019 recipient of their Innovation and Entrepreneurship Award. This press release… Read more
Paragon Biosciences is a life science innovator that invests in, builds, and advises bioscience companies. Their mission is to serve patients living with severe medical conditions which do not yet have adequate treatments. Watch the… Read more
CHICAGO–(BUSINESS WIRE)–Paragon Biosciences Chairman and CEO Jeffrey S. Aronin won a 2019 BIG Innovation Award presented by the Business Intelligence Group. The award honors executives whose leadership improves quality of life. Read the full article… Read more
As Chairman and CEO of Paragon Biosciences, Jeffrey Aronin has invested in and launched several successful portfolio companies, including: Harmony Biosciences, Castle Creek Pharma, Emalex Biosciences, and Skyline Biosciences. Previously, Mr. Aronin served as President and CEO of… Read more
CHICAGO–(BUSINESS WIRE)– Jeff Aronin, Chairman and CEO of Paragon Biosciences, was named 2018’s Innovator of the Year by Best in Biz Awards for his lifelong work towards developing treatments for severe medical conditions. The award… Read more
Jeff Aronin can pinpoint the moment his personal journey in medicine began. Jeff, now the Chairman and CEO of Paragon Biosciences, was working for a company that had developed medication for seizure disorders. To learn… Read more
The Midwest Region hosted a memorable Gala Dinner under the theme of “Breakthrough: Celebrating Discoveries. Shaping Tomorrow.” More than 500 community and industry leaders came together at the Fairmont Chicago Millennium Park to honor Jeffrey… Read more